Multimodal treatment with thiotepa, bevacizumab, teniposide, and tunlametinib in a patient with neurofibromatosis type 1-associated oligodendroglioma: a rare case report
Year: 2025
Type: article
Study design: Case Report
Source: Anti-Cancer Drugs
Authors: Shizhen Zhou, Yanfei Chen, Guoliang Gao, Xueqiang Pan, Peng Sun, Rongjie Tao
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415775726